6-99943117-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001040179.2(MCHR2):c.419G>A(p.Arg140Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,609,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R140L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001040179.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCHR2 | NM_001040179.2 | c.419G>A | p.Arg140Gln | missense_variant | Exon 4 of 6 | ENST00000281806.7 | NP_001035269.1 | |
MCHR2 | NM_032503.3 | c.419G>A | p.Arg140Gln | missense_variant | Exon 4 of 6 | NP_115892.2 | ||
MCHR2 | XM_024446571.2 | c.419G>A | p.Arg140Gln | missense_variant | Exon 4 of 6 | XP_024302339.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151828Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 250120Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135182
GnomAD4 exome AF: 0.000125 AC: 182AN: 1457776Hom.: 0 Cov.: 30 AF XY: 0.000128 AC XY: 93AN XY: 725152
GnomAD4 genome AF: 0.0000988 AC: 15AN: 151828Hom.: 0 Cov.: 31 AF XY: 0.0000944 AC XY: 7AN XY: 74136
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.419G>A (p.R140Q) alteration is located in exon 4 (coding exon 3) of the MCHR2 gene. This alteration results from a G to A substitution at nucleotide position 419, causing the arginine (R) at amino acid position 140 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at